MeSH Browser

MeSH Heading: Sarcoma, Kaposi
Tree Number(s): C01.925.256.466.860; C04.557.450.795.850; C04.557.645.750
Unique ID: D012514
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D012514
Annotation: coordinate IM with precoordinated organ/ neoplasm term (IM)
Scope Note: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
Entry Term(s): Kaposi Sarcoma; Kaposi's Sarcoma; Multiple Idiopathic Pigmented Hemangiosarcoma
Public MeSH Note: 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97
History Note: 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97
Date Established: 1998/01/01
Date of Entry: 1999/01/01
Revision Date: 2019/06/17

Allowable Qualifiers: blood (BL)

blood supply (BS)

cerebrospinal fluid (CF)

chemically induced (CI)

chemistry (CH)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

secondary (SC)

surgery (SU)

therapy (TH)

ultrastructure (UL)

urine (UR)

veterinary (VE)

virology (VI)

Infections [C01]
- Virus Diseases [C01.925]
  - DNA Virus Infections [C01.925.256]
    - Herpesviridae Infections [C01.925.256.466]

Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
  - Neoplasms, Connective and Soft Tissue [C04.557.450]
    - Sarcoma [C04.557.450.795]

Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
  - Neoplasms, Vascular Tissue [C04.557.645]

Sarcoma, Kaposi Preferred

Concept UI: M0019437
Scope Note: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
Terms: Sarcoma, Kaposi Preferred Term
Term UI T037134
Date01/01/1999
LexicalTag EPO
ThesaurusID NLM (1966); Kaposi Sarcoma
Term UI T037133
Date03/30/1974
LexicalTag EPO
ThesaurusID; Kaposi's Sarcoma
Term UI T037132
Date09/27/1996
LexicalTag EPO
ThesaurusID; Multiple Idiopathic Pigmented Hemangiosarcoma
Term UI T782963
Date12/28/2010
LexicalTag NON
ThesaurusID

Sarcoma, Kaposi MeSH Descriptor Data 2024